News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

FzioMed Inc.'s PMA Application for Oxiplex Gel Accepted for Filing by FDA


10/4/2007 7:41:46 AM

SAN LUIS OBISPO, Calif.--(BUSINESS WIRE)--FzioMed, Inc. announced today that the U.S. Food and Drug Administration (FDA) has completed its initial review of the company’s Pre-Market Approval (PMA) application for Oxiplex spine surgery gel and has accepted the PMA for filing. FDA also confirmed that the Oxiplex PMA will receive expedited processing. Oxiplex is intended to reduce pain and symptoms following lumbar spine surgery. FDA granted expedited review status because there are no approved alternative products in the U.S. for this debilitating condition.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES